Stock Information
Ultragenyx Pharmaceutical Inc (RARE)
Ticker Symbol: RARE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,165.92 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -5.8324
Revenue (TTM): $6.74 M
Dividend Yield: N/A%
ROE: -414.17%
Latest News
-
Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference
Wed, May 6, 2026 4:30 PM
-
Ultragenyx Pharmaceutical Inc. (RARE) Q1 2026 Earnings Call Transcript
Wed, May 6, 2026 11:01 AM
-
Wells Fargo Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $47
Wed, May 6, 2026 9:39 AM
-
Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Lowers Price Target to $26
Wed, May 6, 2026 8:43 AM
-
Ultragenyx Pharma (NASDAQ:RARE) Dips After Q1 Miss as Pipeline Catalysts Loom
Tue, May 5, 2026 8:41 PM
-
Transcript : Ultragenyx Pharmaceutical Inc., Q1 2026 Earnings Call, May 05, 2026
Tue, May 5, 2026 7:05 PM
-
Ultragenyx Pharmaceutical Q1 2026 Earnings Call Transcript
Tue, May 5, 2026 6:03 PM
-
Ultragenyx: Q1 Earnings Snapshot
Tue, May 5, 2026 4:09 PM
-
Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update
Tue, May 5, 2026 4:01 PM
-
Earnings Scheduled For May 5, 2026
Tue, May 5, 2026 7:12 AM
Key Financials
Financial data not available
